Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04044170
Recruitment Status : Terminated (Study termination by the Sponsor)
First Posted : August 5, 2019
Last Update Posted : November 17, 2020
Information provided by (Responsible Party):
Hanmi Pharmaceutical Company Limited

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : April 13, 2020
Actual Study Completion Date : April 13, 2020